International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01504152|
Recruitment Status : Completed
First Posted : January 5, 2012
Last Update Posted : July 12, 2013
|Condition or disease||Intervention/treatment|
|Hematopoietic Stem Cell Transplant||Behavioral: questionnaire|
|Study Type :||Observational|
|Actual Enrollment :||519 participants|
|Official Title:||Survey to Assess International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center|
|Study Start Date :||December 2011|
|Actual Primary Completion Date :||July 2013|
|Actual Study Completion Date :||July 2013|
patients who received HSCT at MSKCC between 2005-2010
A self-administered patient questionnaire will be used to collect data that will assess the prevalence of international travel after HSCT and travel related morbidity and exposure risks among HSCT recipients.
The intervention is a self-administered questionnaire that is voluntarily completed by the subject. This questionnaire has been previously validated and demonstrated to be reproducible in English speaking travelers. The final version of the survey questionnaire consists of 49 questions.Patients who never traveled after HSCT will answer only eighteen questions related to their medical and HSCT history in addition to their demographics.
- prevalence of international travel [ Time Frame: 2 years ]of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT
- international travel was during a high-risk specific period [ Time Frame: 2 years ]Proportion of patients traveling to destinations that are at high risk areas for infections
- patients that sought pre-travel health advice [ Time Frame: 2 years ]among those who traveled to high risk areas for infections
- travelers that becomes ill and required medical attention [ Time Frame: 2 years ]during or after return from international travel.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01504152
|United States, New York|
|Memorial Sloan-Kettering Cancer Center|
|New York, New York, United States, 10065|
|Principal Investigator:||Monika Shah, MD||Memorial Sloan Kettering Cancer Center|